STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
Myeloid Therapeutics
DualityBio Inc.
Seagen Inc.
Apollo Therapeutics Ltd
Shanghai Zhongshan Hospital
Mayo Clinic
Massive Bio, Inc.
Actym Therapeutics, Inc.
Travera Inc
TCR2 Therapeutics
Eli Lilly and Company
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
NextPoint Therapeutics, Inc.
TransThera Sciences (Nanjing), Inc.
Tongji Hospital
Instituto do Cancer do Estado de São Paulo
Merus B.V.
Elevation Oncology
Singlera Genomics Inc.
Zymeworks BC Inc.
Travera Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
TransThera Sciences (Nanjing), Inc.
Beijing Friendship Hospital
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
NextCure, Inc.
Universitair Ziekenhuis Brussel
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Hoffmann-La Roche
Klus Pharma Inc.
Tempest Therapeutics
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Bayer
AbbVie
AbbVie
Vanderbilt-Ingram Cancer Center
Peking University Cancer Hospital & Institute
University of Southern California
SpeciCare
Taizhou EOC Pharma Co., Ltd.
University of California, San Francisco
Massachusetts General Hospital